Mp16-01 Clinical Implications of Sunitinib and N-Desethyl-Sunitinib Plasma Concentrations for Treatment Outcome in Metastatic Renal Cell Carcinoma Patients
Journal of Urology - Netherlands
doi 10.1016/j.juro.2017.02.507
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)